Clinical Trial Update: 1% Alendronate Gel in Treatment of Chronic Periodontitis Among Smokers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating 1% alendronate gel for chronic periodontitis in smokers has completed. The snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Alendronate Gel (1%) (alendronate)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Chronic Periodontitis | Phase 2 | Status: COMPLETED